@article{ATM13241,
author = {Patrick C. Ma},
title = {Special issue: “MET as actionable target in cancer therapy”},
journal = {Annals of Translational Medicine},
volume = {5},
number = {1},
year = {2017},
keywords = {},
abstract = {MET (c-Met, or c-MET) receptor is a multifunctional receptor tyrosine kinase that has been known for many years of its pivotal role in human developmental and cancer signaling. The natural ligand for MET is hepatocyte growth factor [HGF; also called scatter factor (SF)], which can act in autocrine, endocrine or paracrine fashion on the MET-expressing epithelial cells (1).},
issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/13241}
}